These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 22277037)
1. [Does rational therapy exist in patients with Crohn's disease and ulcerative colitis?]. Lukás M Vnitr Lek; 2011 Dec; 57(12):1029-33. PubMed ID: 22277037 [TBL] [Abstract][Full Text] [Related]
2. [Compared azathioprine efficacy in ulcerative colitis and in Crohn's disease]. Kull E; Beau P Gastroenterol Clin Biol; 2002 Apr; 26(4):367-71. PubMed ID: 12070412 [TBL] [Abstract][Full Text] [Related]
3. Current status of drug therapy for inflammatory bowel disease. Peppercorn MA Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866 [TBL] [Abstract][Full Text] [Related]
4. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis. Niederau C; Backmerhoff F; Schumacher B; Niederau C Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126 [TBL] [Abstract][Full Text] [Related]
5. [5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)]. Maier K; Fischer C; Klotz U; Heinkel K Dtsch Med Wochenschr; 1982 Jul; 107(29-30):1131-4. PubMed ID: 6123426 [TBL] [Abstract][Full Text] [Related]
6. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration. Nathan DM; Iser JH; Gibson PR J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377 [TBL] [Abstract][Full Text] [Related]
8. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Ho GT; Chiam P; Drummond H; Loane J; Arnott ID; Satsangi J Aliment Pharmacol Ther; 2006 Jul; 24(2):319-30. PubMed ID: 16842459 [TBL] [Abstract][Full Text] [Related]
9. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital. Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056 [TBL] [Abstract][Full Text] [Related]
10. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases]. Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579 [TBL] [Abstract][Full Text] [Related]
11. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease. Folwaczny C; Wiebecke B; Loeschke K Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024 [TBL] [Abstract][Full Text] [Related]
13. Therapeutical experiments in ulcerative colitis and Crohn's disease. Nagy G; Prónay G; Ujszászy L Acta Med Hung; 1985; 42(3-4):163-74. PubMed ID: 2869469 [TBL] [Abstract][Full Text] [Related]
14. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif]. Pagenault M; Tron I; Alexandre JL; Cruchant E; Dabadie A; Chaperon J; Robaszkiewicz M; Bretagne JF Gastroenterol Clin Biol; 1997; 21(6-7):483-90. PubMed ID: 9295976 [TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis. Hibi T; Iwao Y; Yajima T; Inoue N; Ueno Y; Takaishi H; Watanabe M; Ishii H J Gastroenterol; 1995 Nov; 30 Suppl 8():121-3. PubMed ID: 8563872 [TBL] [Abstract][Full Text] [Related]
16. [Long-term therapy in ulcerative colitis and Crohn's disease]. Malchow H Fortschr Med; 1979 Aug; 97(29):1253-60. PubMed ID: 457018 [TBL] [Abstract][Full Text] [Related]
18. [Incidence of inflammatory bowel diseases in the department of Puy-de-Dôme in 1993 and 1994. EPIMICI. Epidémiologie des Maladies Inflammatoires Cryptogenetiques de l'Intestin group]. Flamenbaum M; Zénut M; Aublet-Cuvelier B; Larpent JL; Fabre P; Abergel A; Dapoigny M; Bommelaer G Gastroenterol Clin Biol; 1997; 21(6-7):491-6. PubMed ID: 9295977 [TBL] [Abstract][Full Text] [Related]
19. [Infliksimab in therapy of inflammatory bowels diseases]. Kniazev OV; Lazebnik LB; Ruchkina IN; Tsaregorodtseva TN; Parfenov AI Eksp Klin Gastroenterol; 2009; (5):64-8. PubMed ID: 20201307 [TBL] [Abstract][Full Text] [Related]